Schrodinger, Inc. EBITDA Margin 2019-2024 | SDGR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Schrodinger, Inc. (SDGR) over the last 10 years. The current EBITDA margin for Schrodinger, Inc. as of September 30, 2024 is .
| Schrodinger, Inc. EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.19B | $-0.21B | -109.84% |
| 2024-06-30 | $0.20B | $-0.20B | -99.50% |
| 2024-03-31 | $0.19B | $-0.21B | -110.58% |
| 2023-12-31 | $0.22B | $-0.17B | -79.26% |
| 2023-09-30 | $0.20B | $-0.17B | -85.50% |
| 2023-06-30 | $0.19B | $-0.16B | -82.99% |
| 2023-03-31 | $0.20B | $-0.14B | -72.59% |
| 2022-12-31 | $0.18B | $-0.14B | -78.45% |
| 2022-09-30 | $0.17B | $-0.14B | -80.59% |
| 2022-06-30 | $0.16B | $-0.13B | -77.30% |
| 2022-03-31 | $0.16B | $-0.11B | -73.55% |
| 2021-12-31 | $0.14B | $-0.11B | -78.99% |
| 2021-09-30 | $0.13B | $-0.10B | -82.40% |
| 2021-06-30 | $0.12B | $-0.08B | -69.42% |
| 2021-03-31 | $0.11B | $-0.07B | -61.40% |
| 2020-12-31 | $0.11B | $-0.06B | -53.70% |
| 2020-09-30 | $0.10B | $-0.05B | -48.51% |
| 2020-06-30 | $0.10B | $-0.04B | -46.32% |
| 2020-03-31 | $0.09B | $-0.04B | -45.05% |
| 2019-12-31 | $0.09B | $-0.04B | -40.70% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||